Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial - Aix-Marseille Université
Article Dans Une Revue Journal of Hepatology Année : 2018

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

Fichier non déposé

Dates et versions

hal-02471037 , version 1 (07-02-2020)

Identifiants

Citer

Richard Finn, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, et al.. Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial. Journal of Hepatology, 2018, 69 (2), pp.353-358. ⟨10.1016/j.jhep.2018.04.010⟩. ⟨hal-02471037⟩
54 Consultations
0 Téléchargements

Altmetric

Partager

More